Abeona Therapeutics Inc.

(ABEO) Trade

By |

Profile

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. The gene therapy involves the use of DNA as a potential therapy to treat a disease. The company's initial programs are focused on lysosomal storage diseases such as Mucopolysaccharidosis (MPS) IIIA and IIIB. It is also developing ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten Disease, respectively, ABO-401 for the treatment of cystic fibrosis, and ABO-5OX for the treatment of retinal diseases.

Contact Information

Website: www.abeonatherapeutics.com
Email: mberg@abeonatherapeutics.com
Main Phone: +1 646 813-4712
Address: 1330 Avenue of the Americas
Address 2: 33rd Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Joao Siffert
Employees: 83
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

Profile

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. The gene therapy involves the use of DNA as a potential therapy to treat a disease. The company's initial programs are focused on lysosomal storage diseases such as Mucopolysaccharidosis (MPS) IIIA and IIIB. It is also developing ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten Disease, respectively, ABO-401 for the treatment of cystic fibrosis, and ABO-5OX for the treatment of retinal diseases.

Contact Information

Website: www.abeonatherapeutics.com
Email: mberg@abeonatherapeutics.com
Main Phone: +1 646 813-4712
Address: 1330 Avenue of the Americas
Address 2: 33rd Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Joao Siffert
Employees: 83
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

$ 2.25 $ 0.08 (3.69%)
Last Price 2.25 Change $ 0.08 Change % 3.69 Tick N/A
Bid 2.25 Bid Size 3,800.00 Ask 2.26 Ask Size 1,600.00
Open 2.16 High 2.30 Low 2.12 Prev Close 2.17
Last Trade Volume 364,096 52 Wk Hi 10.37 52 Wk Low 1.46
Market Cap 111 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 49,315,751.00 EPS (TTM) -1.64 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Todd Wider 1,000
Mark J. Ahn 1,000
Todd Wider 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 36 36 36 36
Low Target Price Estimate 23 23 23 23
Mean Target Price Estimate 29.5 29.57 29.57 29.5
Standard Deviation 4.87 5.26 5.26 4.87
Date of Most Recent Estimate 06/05/18 05/22/18 05/22/18 06/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 6 6 6
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.13 1.14 1.14 1.14